Novo Nordisk A/s

Ferrosan Medical Devices A/s

Mads Christian Sabra

Kristian Larsen

Thomas Buch-Rasmussen

Henrik Egesborg Hansen

Lene Møller

Kristina Devantier

Trine Wulff

Lene Moller

Lene MØLLER

Disclosed is a matrix material comprising a pharmaceutical composition such as a matrix material with a pharmaceutical composition printed on the surface. In one embodiment the pharmaceutical composition comprises thrombin. Further disclosed is a method for making the matrix material with a pharmaceutical composition printed on the surface and use of said matrix material for promotion of hemostasis and/or wound healing. Also disclosed is a kit-of-parts comprising a matrix with a pharmaceutical composition and a container with a peelable lid.

Device for promotion of hemostasis and/or wound healing

A matrix material comprising a pharmaceutical composition printed on the surface is described. In one embodiment the pharmaceutical composition comprises thrombin. A method for making the matrix material with a pharmaceutical composition printed on the surface is also described. The matrix material can be used for promotion of hemostasis and/or wound healing. A kit-of-parts comprising a matrix with a pharmaceutical composition and a container with a peelable lid is described.

A solid pharmaceutical composition for parenteral administration having an inner matrix containing at least one therapeutic agent, and a biodegradable, and water-impermeable coating covering part of the surface of said composition. The inner matrix disintegrates upon contact with animal tissue or tissue fluids. By providing a disintegratable and/or soluble inner matrix comprising the drug with a water-impermeable coating covering part of the surface of said composition, the rate of release of the drug can be controlled. The specific rate of release can be controlled by carefully designing the part of the surface which is not covered.

Solid dose micro implant

An apparatus for insertion of a medicine peg () into the skin () has a barrel () wherein the medicine peg () is stored and in which a plunger () behind said peg () can be moved to press the peg out through an end of the barrel () pressed against the skin () where it is intended to insert the peg (), The plunger () is a part of a flexible rod construction () which can be passed from a first non rectilinear constellation, by which the plunger () is withdrawn in the barrel () to a position leaving space for the medicine peg () in front of the plunger (), to a rectilinear constellation by which the plunger () projects from the end of the barrel () and further to a new non rectilinear position in which the end of the plunger () is withdrawn in the barrel ().

Apparatus for automatic insertion of a solid medicine

The present invention relates to a haemostatic composition comprising a biologically absorbable material and hyaluronic acid or a derivative thereof, methods of producing such compositions and the use of these compositions. In particular the method of producing said haemostatic composition comprises treating it with dry heat at a temperature between 110-200&#xb0; C.

Haemostatic composition comprising hyaluronic acid

The invention relates to a concept for placing a subcutaneous device such as a sensor at a selected site within the body of a patient, e.g. to obtain blood glucose readings. In a first aspect, an insertion needle comprises an oblong needle body and a distal end portion, the distal end portion having a pointed distal tip allowing the needle to be introduced subcutaneously and a distally facing generally smooth surface, the body comprising along a portion thereof a longitudinal groove adapted to at least partially accommodate the subcutaneous device. In a second aspect, a combination of an insertion needle and a subcutaneous device form an oblong body portion and a distal end portion formed by either of the members or in combination by the two members, the distal end portion having a pointed distal tip and a distally facing generally smooth surface. By the above configuration, a concept is provided reducing the severity of the body response following transcutaneous placement of a device as well as reducing the pain associated with the insertion.

Growing community of inventors

Kobenhavn, Denmark

Mads Christian Sabra